Global world's leading technology industrialization transformation platform of IVD field
About GeneoDx

Shanghai GeneoDx Biotech Co., Ltd. (GeneoDx) is a subsidiary of China National Biotec Group Company Limited (CNBG), China National Pharmaceutical Group Co., Ltd. (Sinopharm). GeneoDx is a professional R&D, production, and sales company of domestic and foreign medical devices and in vitro diagnostic reagents.

 

Medical diagnosis is one of the key sectors in the development of CNBG's planning. GeneoDx undertakes this part in CNBG. It is also the first company leading CNBG's mixed ownership reform, aiming to promote the rapid development of diagnostic business with institutional innovation. As a unified operation platform company of CNBG's diagnosis sector, GeneoDx integrates functions of R&D, production and trade. By means of independent research and development, technology import, investment, merger and acquisition, it has built a large industrial chain of CNBG's diagnosis sector, and strives to become a leader in the domestic subdivision field. In 2019, GeneoDx completed the first acquisition project of a foreign company within Sinopharm Group, launched the construction of an overseas R&D center, therefore, further accelerated the introduction of global leading technology and broadened the layout overseas.

  • Value
    Value

    Love and responsibility

  • Vision
    Vision

    Focusing on the core fields of molecular diagnostics, the company gradually expands its fields to Chemiluminescence analysis(CLIA), POCT and Immunoassay, and has built competitive product lines and a strong marketing network, becoming a well-known enterprise in China's medical diagnostic industry.

  • Philosophy
    Philosophy

    All for health, health for all

Value

Love and responsibility

Vision

Focusing on the core fields of molecular diagnostics, the company gradually expands its fields to Chemiluminescence analysis(CLIA), POCT and Immunoassay, and has built competitive product lines and a strong marketing network, becoming a well-known enterprise in China's medical diagnostic industry.

Philosophy

All for health, health for all

CEO Speech
Thanks to friends from all walks of life for the long-term concern and support of GeneoDx!

Shanghai GeneoDx Biotech Co., Ltd. was established in 1991. After more than 30 years of opeation, we have achieved a large industrial chain of CNBG's diagnosis sector with functions of R&D, production and trade, by means of independent research and development, technology import, investment, merger and acquisition, striving to become a leader in the domestic in the segmentation field. 

The steady development of GeneoDx is inseparable from the deep concern of Party committees and governments at all levels, the recognition and support of all sectors of society, and the joint efforts of all staffs of GeneoDx.

In the future, GeneoDx will continue to focus on the field of biomedicine, adhere to the corporate philosophy of "All for health, health for all", and the core values "love and responsibility", pass on the value, honor, trust, respect, mission and commitment to the employees; equal cooperation and sincere reciprocity to the partners; health and love to the community. We will improve our products and services to better human health.

I believe that under the joint efforts of my colleagues and me, GeneoDx will brave challenges,with innovation and determination, taking providing high-quality biological products and services as its orientation, operating from China to the world, to become of a biomedicine enterprise with international influence .

We are willing to join hands with all friends, unity and forge ahead, to make a better future!

Development History
2022.8

Obtained the first certificate of cervical cancer HPV screening methylation triage in China, DNA Methylation Detection Kit for Human ASTN1、DLX1、ITGA4、RXFP3、SOX17、ZNF671 Gene -- Cervical Cancer
In the future, as a professional company in CNBG's diagnostics sector, GeneoDx will continue to focus on the core fields of molecular diagnostics, expand its fields to Chemiluminescence analysis(CLIA), POCT and Immunoassay, build competitive product lines and marketing networks, to become a well-known enterprise in China's medical diagnostic industry.

2022

In 2022, a number of medical laboratories was established, including Shanghai GeneoDx Medical Laboratory, Shanghai GeneoDx Vizenen Medical Laboratory, Beijing GeneoDx Medical Laboratory and Lanzhou Medical Laboratory, to establish a national third-party medical laboratory with characteristics in tumor and pathogenic microorganism detection.

2021

In 2021, the company acquired Yaxin Biotech Co, Ltd., an animal-free recombinant biomedical enzyme manufacturer, and committed itself to the localization and standardization of CNBG enzymes to alleviate the "bottleneck" problem.

2020

In 2020, GeneoDx was among the first groups to obtain the registration certificate of novel coronavirus detection kits. The subsidiary GeneSc has been established to introduce the rapid nucleic acid detection technology of novel coronavirus and is committed to promoting the research and development of home self-testing reagents and supporting instruments.

2019

In 2019 GeneoDx acquired PathoFinder in the Netherlands to establish an overseas research and development base, imported four fungi and fungal resistance detection techniques; cooperated with Huashan Hospital and Fudan University to develop reagent projects for the development of four patent technologies for serious drug rash related gene testing.

2018

In 2018, GeneoDx introduced cervical cancer methylation detection technology, multiple encephalitis meningitis, intestinal and venereal acid detection technology, which has enriched the product line.

2017

In 2017, the company moved from Changchun to Shanghai and changed its name to Shanghai GeneoDx Biotech Co., Ltd. At the same time, it completed the mixed ownership reform, which energized the company by the way of core employee ownership; introduced nucleic acid detection technology of multiple respiratory pathogens, and started the transformation road from a trading company to a research and development company.

1991

Founded on July 12, 1991, formerly known as Changchun Institute of High-tech Application, it is a wholly owned subsidiary of Changchun Institute of Biological Products.

2022.8
2022
2021
2020
2019
2018
2017
1991
Honors
Completed the first acquisition project of equity of a foreign company within Sinopharm, started the construction of overseas research and development center, further accelerated the introduction of international advanced technology, and expanded the process of international layout.

"Innovation Star" of China National Biotech Group

Shanghai "Specialized, Special and New" Small and Medium-Sized Enterprise

High and New Technology Enterprise (HNTE)

Shanghai Model Collective

Small and Medium-Sized S&T Enterprise

Shanghai Science and Technology “Little Giant” Firm

2020 Outstanding Scientific Innovation Enterprise Award, Xuhui District, Shanghai

The All-China Federation of Industry and Commerce Advanced Private Enterprises in the Fight Against Covid-19

Shanghai Xuhui District Food and Drug Safety Association 2020 Advanced Collective for Prevention and Control of Epidemic Prevention

Sinopharm Advanced Collective in the Fight Against Covid-19

CNBG Order of the Prevention and Control of Covid-19 Pandemic

Changchun Advanced Grass-Roots Party Organization

Advanced Individual in Shanghai's Fight Against Covid-19

Excellent Communist Party Member of Sinopharm

Model Worker of Sinopharm

Young Role model of Sinopharm

Excellent Communist Party Member of Changchun Company

Top Talent in Xuhui District

Academic Pacemaker of Xuhui District

Xuhui District "Dedication" Moral Model

Shanghai Xuhui District Food and Drug Safety Association 2020 Advanced Individual for Prevention and Control of Covid-19

The Third Xuhui District Government Quality Award

"Science and Innovation China" Young Entrepreneurs List -- the Yangtze River Delta G60 Science and Innovation Corridor U30 and Xingyao G60 Entrepreneurship Talent list

2020寮步塘边市场小妹,寮步南美沐足有爱做,寮步下岭贝快餐服务_女优